• Mashup Score: 2
    EHRA-PATHS - 2 year(s) ago

    This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 945260 The EHRA-PATHS project aims to transform and improve the clinical practice in the field of AF to holistic, inclusive and…

    Tweet Tweets with this article
    • #AFneverComesAlone! I van Gelder on #EHRA_PATHs @ehrapaths 👉🏻https://t.co/Fv0pARa1q1 Addressing multimorbidity in #AFib pts through interdisciplinary, patient-centred, systematic care pathways! #WAfib2022 @westernAFib @nmarrouche @HorizonEU https://t.co/0cgz9Y0PO7

  • Mashup Score: 5
    Project – EHRA-PATHS - 2 year(s) ago

    What is Atrial Fibrillation?Atrial fibrillation (AF) is a heart rhythm disease characterized by an irregular beating of the atrial chambers of the heart. AF is the most common form of arrhythmia and it is associated with a 5-10 fold increased risk of cardiovascular and neurological conditions such as heart failure, stroke and dementia….

    Tweet Tweets with this article
    • Dr. Van Gelder mentions the EHRA-PATHS project for "holistic, inclusive and personalised treatment strategies" for #Afib More here: https://t.co/OW3IYSBf7N #WAFib2022 https://t.co/RT6bvJu2pq

  • Mashup Score: 1

    This 2 × 2 factorial trial compares the effects of omega-3 fatty acids (460 mg/d of EPA and 380 mg/d of DHA) vs placebo, vitamin D₃ vs placebo, both, or neither on risk of incident atrial fibrillation (AF) among adults aged 50 years or older over a median of more than 5 years of treatment.

    Tweet Tweets with this article
    • .@CMAlbertEP on the VITAL-AF RCT: Omega-3 fatty acids & Vit D effect on #AFib: *>25,000 participants, 5y f/u * No benefit for either agent on AF * Slight risk of incr AF with Vit D (1.09 OR) https://t.co/dy8dueI1Wq #WAFib2022 https://t.co/2qPAOeu9Rw